|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/517 | |||
| A61K 31/661 | |||
| A61K 31/7064 | |||
| A61K 45/06 | |||
| B82Y 5/00 | |||
| A61P 35/00 | |||
| A61K 47/42 | |||
| A61K 9/51 | |||
| A61K 31/675 |
| (11) | Number of the document | 2367425 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09832656.4 |
| Date of filing the European patent application | 2009-12-11 | |
| (97) | Date of publication of the European application | 2011-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/067766 |
| Date | 2009-12-11 |
| (87) | Number | WO 2010/068925 |
| Date | 2010-06-17 |
| (30) | Number | Date | Country code |
| 201624 P | 2008-12-11 | US | |
| 178430 P | 2009-05-14 | US |
| (72) |
TRIEU, Vuong, US
D`CRUZ, Osmond, US
DESAI, Neil, P., US
|
| (73) |
Abraxis BioScience, LLC,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | Combination therapy including a taxane and a further therapeutic agent |
| Combination therapy including a taxane and a further therapeutic agent |